Squarepoint Ops LLC

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 1642575 NEW YORK, NY

Position in CRVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$660,422

-$1,152,176 QoQ

Shares Held

44,205

-64.3% QoQ

Ownership

0.053%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#87

of 172 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. CRVS ranks #127 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$660,422	44,205	-64.3%	Shares	Defined	2026-08-14
2026-03-31	$1,812,598	123,896	+18.2%	Shares	Defined	2026-05-15
2025-12-31	$807,114	104,820	+6.8%	Shares	Defined	2026-02-13
2024-12-31	$525,070	98,144	+712.5%	Shares	Defined	2025-02-14
2024-09-30	$63,782	12,080	-29.3%	Shares	Defined	2024-11-14
2023-06-30	$39,117	17,082	+30.2%	Shares	Defined	2023-08-14
2021-12-31	$31,614	13,118	-34.3%	Shares	Defined	2022-02-14
2021-09-30	$96,577	19,954	-24.5%	Shares	Defined	2021-11-15
2020-06-30	$71,856	26,418	+8.1%	Shares	Defined	2020-08-14
2020-03-31	$51,559	24,436	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.